Cargando…
Reply to te Brake et al.: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis
Autores principales: | Velásquez, Gustavo E., Brooks, Meredith B., Coit, Julia M., Sánchez Garavito, Epifanio, Calderón, Roger I., Jiménez, Judith, Tintaya, Karen, Peloquin, Charles A., Osso, Elna, Lecca, Leonid, Davies, Geraint R., Mitnick, Carole D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515881/ https://www.ncbi.nlm.nih.gov/pubmed/30645140 http://dx.doi.org/10.1164/rccm.201812-2281LE |
Ejemplares similares
-
Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial
por: Milstein, Meredith, et al.
Publicado: (2016) -
Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis
por: te Brake, Lindsey H. M., et al.
Publicado: (2019) -
Accuracy of digital chest x-ray analysis with artificial intelligence software as a triage and screening tool in hospitalized patients being evaluated for tuberculosis in Lima, Peru
por: Biewer, Amanda, et al.
Publicado: (2023) -
Low detection rate of RT-PCR-confirmed COVID-19 using IgM/IgG rapid antibody tests in a large community sample in Lima, Peru
por: Law, Stephanie, et al.
Publicado: (2023) -
FAST tuberculosis transmission control strategy speeds the start of tuberculosis treatment at a general hospital in Lima, Peru
por: Tierney, Dylan B., et al.
Publicado: (2022)